Nepal drug administration reject six Patanjali products after tests, contain pathogenic bacteria
Nepal's drugs watchdog has asked Baba Ramdev's Patanjali to recall six medicines after they were found to be of 'substandard quality' following lab tests.
Kathmandu: Nepal's drugs watchdog has asked Baba Ramdev's Patanjali Ayurveda to recall six Ayurvedic medicines after they were found to be of "substandard quality" following microbial tests.
The Department of Drug Administration, in a public notice, said six Ayurvedic medical products made by Divya Pharmacy in Uttarakhand, were found to be substandard during inspections at various outlets and tests on specimens.
The medicines which failed the microbial tests are Patanjali's Amla Churna, Divya Gashar Churna, Bahuchi Churna, Triphala Churna, Aswangandha and Adviya Churna, the notice said.
"The batch of medicine which were inspected by the department are found to have contained pathogenic bacteria," an official of the Department told PTI.
The Nepalese drug authorities have urged the stakeholders not to sell or prescribe the use of these six medicines with immediate effect.
A source at Patanjali Ayurveda Kendra in Kathmandu, the sole distributor of the products in Nepal, said the medicines have not been banned but restriction was imposed on the sale and use of certain batch of the medicines that failed lab test.
"We will immediately recall the medicines if found substandard," he said.
The top court had taken suo motu cognisance and said it cannot allow the UP government "to hold 100 percent physical Kanwar Yatra in view of COVID"
Sidhu’s statement came a day after AAP MP Bhagwant Mann questioned him about the ‘funds’ allegedly accepted by the Congress from private power companies in the state
A five-member Constitutional Bench issued a mandamus to appoint Deuba as the prime minister by Tuesday. Deuba, 74, has served as the prime minister on four occasions